Lightbody Lecture 12 Flashcards

1
Q

E stores in typical body

A

135000kcal fats (85% of body’s stored E), 24000kcal prot, 720kcal glycogen, 80kcal blood glucose (gluc can last 1 day)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

beta oxidation

A

ox of FAs; takes place in mito matrix; FAs broken down into 2C frags (aCoA) which enter TCA or conv to ketone bodies in liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ATGL - adipocyte TAG lipase

A

hydrolyzes only TAG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

HSL - hormone sensitive lipase

A

hydrolyzes TAG and DAG; + by isoproteronol (stims adren receps), + by phos by PKA and PKG (translocates from cyto to perilipin-cont droplets, - by insulin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

MGL - monoglyceride lipase

A

hydrolyzes only MAG

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

acyl CoA synthetase

A

takes R-COO- FA and ATP, becomes acyl-adenylate intermed, then use again w/CoASH to become acyl-CoA + AMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

key process in fat metab

A

hydrolytic cleavage of stored TAG w/gen of FA and glycerol and their release from adipocytes where they’re transported, complexed w/albumin, to various tissues to be used as E

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

perilipin

A

coats lipid droplets in adipocytes; acts as protective coating agst lipases; non-phos (coats lipid droplet) or phos (by PKA and PKG, changes conf, exposing stored lipids to HSL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

carnitine acyltransferase I

A

in carnitine shuttle; - by malonyl CoA, makes O-acylcarnitine from L-carnitine, then O-acylcarnitine gets translocated and acyls transferred to move L-carnitine into cell

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

FA activation

A

after leave adipocytes, transported (att to albumin) to other tissue (m, heart, liver); short and med chain (<12) can x mito memb, activated in matrix; long (12-20) activ at outer mito memb, transported into mito by carnitine shuttle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

b-oxidation

A

dehydrogenase w/FAD as e- acceptor, then hydration, then dehydrogenase w/NAD as e- acceptor, then cleave CC bond (thiolase)–>acetyl-CoA and new fatty acyl-CoA w/2 fewer C units

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

b-oxid of palmitic acid (C16)

A

7 cycles; 131-2 = 129 ATP from activation; in mito matrix

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

2 mito systems of b oxidation

A

1) fam of memb-bd enz’s spec for long-chain FAs; 2) soluble enz’s in matrix spec for short and med chain FAs; as long shortens, moves from memb-bd complex to soluble matrix enz’s (maj of FAs entering mito are long-chain)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

metab of odd-chain FAs

A

propionyl-CoA-carboxylase->D-methylmalonyl-CoA-racemase->L-methylmalonyl-CoA-mutase->succinyl-CoA–>TCA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

oxid of unsat FAs

A

almost all unsat FAs cont only cis DBs; hydratase acts only on trans, so need isomerase (oleoyl-CoA; eventually become acetyl-CoA, but need an isomerase to make cis–>trans, then use hydratase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

carnitine cycle mito fat oxid disorders

A

involves LCFA transport thru inner mito memb

17
Q

disorders of mito fat oxid in general lead to

A

cardiomyopathy, hypoglycemia, hypokeosis, myopathy, encephalopathy; defs in carnitine cycle or inner memb can be partially overcome by giving MCFA or SCFA (milk)

18
Q

inner memb sys mito fat oxid disorders

A

mainly shortening of LCFAs thru b-oxid

19
Q

mito matrix fat oxid disorders

A

oxids FAs of shorter length, doesn’t involve carnitine

20
Q

artificially induced trans fatty acids

A

hydrogenate polyunsat cis oils–>bonds that don’t reduce change from cis to trans (margarines) - not oxidized easily, so reduce rancidity, inc shelf life; cont no animal fats; raise LDL, lower HDL; contrib to coron heart dis, cancer, diab, obesity, liver dysfxn

21
Q

ketone bodies

A

FAs metab to acetyl-CoA by b-ox, then condense to form KBs; synth ONLY in liver mito; secreted into blood, transported to other tissue (heart, m, kidney, brain), reconv to acetyl-CoA, used as E; liver cannot metabolize them!; synth small quant all the time, but in starvation, unctrl’d diab I synth in lg quants

22
Q

synth of ketone bodies

A

acetyl-CoA–>acetoacetylCoA–>3-hydroxy-3-methylglutaryl-CoA (HMG-CoA–also in chol synth)–>acetoacetate–>acetone + b-hydroxybutarate

23
Q

metab of ketone bodies

A

water sol equiv of FAs; brain can use in starvation

24
Q

thiophorase

A

needed to metab KBs; liver deficient in this, so can only synth, not metab!

25
Q

fasting, starvation, severe T1D

A

OAA (via malate) leaves mito, used for glucose synth (GNG)–>shuts down TCA; at time, liver prod A-CoA by b-ox of FAs, but has nowhere to go, so condenses to KBs; glc levels maint by glycerol, RBC lactate, AA brkdn (major source)

26
Q

KB utilization

A

rel into systemic blood (acetone elim in urine, exhaled; acetoacetate and b-hydroxybutarate used as fuels); convert to E (b-hydroxybut and acetoacetate conv to acetoacetyl CoA using succ CoA from TCA; cleaved to 2-acetyl-CoA); range of tissues can use (brain when starved, thiophorase induced after 4d of starvation, derive 50% of E from KB); excess–>acidosis, relieved thru elim of KBs thru urine

27
Q

Atkins

A

high fat, low carbs–>fat mobil and KBs in urine; active fat metab and GNG; check for KB in urine–>sign that fat metab; discouraged b/c metabolic acidosis

28
Q

KBs and T1D

A

diab–>high glc in blood; transport into tissues reduced; resp by inc GNG in liver, inc TAG brkdn in adipocytes; FAs transp to liver for ox, consuming most of OAA; no OAA, so excess a-CoA condenses–>KBs (detect acetone on breath)

29
Q

peroxisomes

A

synth bile acids, lipids, H peroxide, detox; live a few days; brkdn VLCFAs (C22-30), both sat and unsat; cont all b-oxid enz’s (enz that activates VLCFA (acylCoA synthetase) only in this organelle); have sep transporter, so don’t need carnitine; b-oxid only goes a few cycles, then rel’d to mito for further oxid

30
Q

catalase

A

degrades H2O2 in peroxisome; 2H2O2–>2H2O + O2; don’t prod ATP

31
Q

FADH2 in peroxisome

A

gen’d by b-oxid; reox–>H peroxide; difers from mito where this enters e-transport chain (FADH2 + O2 –> FAD + H2O2)

32
Q

NADH formed in peroxisome

A

can’t be reox here, so has to be exported out

33
Q

A-CoA formed in peroxisome

A

must transfer out b/c TCA cycle enz’s absent

34
Q

X-ALD

A

dec in abil for peroxisomes to degrade VLCFAs, so build up in adrenal, brain, plasma, fibroblasts–>interfere w/abil of adrenal to conv chol into steroid, demyelin nn in brain; appear @4-10yo (behav /\, bad vision, hearing, coord); death 2-4y later

35
Q

X-ALD defect

A

ATP bdg ABCD1 transporter prot (ALDP), crucial for transport of VLCFAs into peroxisomes; treat w/Lor oil or stem cell therapy

36
Q

Lorenzo’s Oil

A

4:1 mix of oleic acid and erucic acid from olive and rapeseed oil; must give before symps present, low fat diet; retard disease (maj of VLCFAs accum are sat FAs from diet and synth)

37
Q

elongase

A

synth saturated VLCFAs; elongates both sat and unsat FAs; monounsat FAs compete for this enz, lowering synth of sat VLCFAs